Adolescent cannabis use and risk of depression and suicide

shutterstock_618029801

Benjamin Janaway blogs about a major data analysis that links adolescent cannabis use with increased risk of depression and suicide. He considers the opportunities for early recognition of cannabis use and public intervention.

[read the full story...]

Daily skunk cannabis use associated with a 5-fold increase in psychosis risk

lexscope-388938-unsplash

Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.

[read the full story...]

Medical cannabis for mental illness: current use is not supported by research #MHQT

sharon-mccutcheon-798864-unsplash

As we prepare for our Cannabis #MHQT event on Wed 26 Sep, Luke Sheridan Rains dissects a narrative review that asks: Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

His answer is that current evidence does not support the use of medical cannabis for mental illnesses such as anxiety or depression.

[read the full story...]

High potency cannabis and the risk of psychosis

shutterstock_27220114

Eleanor Kennedy writes her debut blog on a recent case-control study of people in South London, which explores the links between first-episode psychosis and the use of high potency cannabis (skunk).

[read the full story...]

Pharmacotherapies for reducing cannabis dependence

Cannabis

Kathryn Walsh reports on a recent Cochrane systematic review of pharmacotherapies for cannabis dependence, which concludes that there is a lack of evidence for all medications reviewed.

[read the full story...]